Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome

Article information

J Stroke. 2021;23(1):146-146

Publication date (electronic) : 2021 January 31

doi : https://doi.org/10.5853/jos.2020.01004.e1

Ze’ev Itsekson-Hayosh ^a^,^b^,^*, Galia Tsarfaty ^c^,^*, Gahl Greenberg ^c, Michal Sharon ^c, Mati Bakon ^c, Anton Wohl ^d, Joab Chapman ^a^,^b^,^e, David Orion ^a^,^b

^aComprehensive Stroke Center, Department of Neurology and The J. Sagol Neuroscience Center, The Chaim Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel

^bDepartment of Neurology, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel

^cInstitute of Medical Imaging, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel

^dDepartment of Neurosurgery, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel

^eRobert and Martha Harden Chair in Mental and Neurological Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

*These two authors contributed equally to this study.

This corrects the article "Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome" in Volume 22 on page 400.

J Stroke 2020;22(3):400-402

https://doi.org/10.5853/jos.2020.01004

In the article, there is a spelling mistake of second author’s name, and they want to change to Galia Tsarfati from Galia Tsarfaty.

We apologize for any inconvenience that this may have caused.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.